sábado, 21 de noviembre de 2015

CDC - 2009 CAUTI Guideline - HICPAC

CDC - 2009 CAUTI Guideline - HICPAC



Guideline for Prevention of Catheter-associated Urinary Tract Infections, 2009

2009 CAUTI Guidelines Adobe PDF file(407 KB / 67 pages) and Appendices Adobe PDF file (4.41 MB / 268 pages) are available for download in PDF format.
Carolyn V. Gould, MD, MSCR 1; Craig A. Umscheid, MD, MSCE 2; Rajender K. Agarwal, MD, MPH 2; Gretchen Kuntz, MSW, MSLIS 2; David A. Pegues, MD 3 and the Healthcare Infection Control Practices Advisory Committee (HICPAC)4
1Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention
Atlanta, GA
2 Center for Evidence-based Practice
University of Pennsylvania Health System
Philadelphia, PA
3 Division of Infectious Diseases
David Geffen School of Medicine at UCLA
Los Angeles, CA

Healthcare Infection Control Practices Advisory Committee (HICPAC)


Chair

BRENNAN, Patrick J., MD
Chief Medical Officer
Division of Infectious Diseases
University of Pennsylvania Health System

Executive Secretary

BELL, Michael R., MD
Associate Director for Infection Control
Division of Healthcare Quality Promotion
National Center for Infectious Diseases
Centers for Disease Control and Prevention

Members

BURNS, Lillian A., MPH
Infection Control Coordinator
Infectious Diseases Department, Greenwich Hospital
ELWARD, Alexis, MD, MPH
Medical Director of Infection Control
Assistant Professor, Pediatric Infectious Diseases
Washington University School of Medicine
ENGEL, Jeffrey, MD
Chief, Epidemiology Section, North Carolina Division of Public Health
North Carolina State Epidemiologist
LUNDSTROM, Tammy, MD, JD
Chief Medical Officer
Providence Hospital
GORDON, Steven M., MD
Chairman, Department of Infectious Diseases
Hospital Epidemiologist
Cleveland Clinic Foundation
MCCARTER, Yvette S., PhD Director, Clinical Microbiology
Laboratory
Department of Pathology
University of Florida Health Science
Center-Jacksonville
MURPHY, Denise M., MPH, RN, CIC
Vice President, Safety and Quality
Barnes-Jewish Hospital at Washington
University Medical Center
OLMSTED, Russell N., MPH
Epidemiologist
Infection Control Services
St. Joseph Mercy Health System
PEGUES, David Alexander, MD
Professor of Medicine, Hospital Epidemiologist
David Geffen School of Medicine at
UCLA
RAMSEY, Keith M., MD
Professor of Medicine
Medical Director of Infection Control
Pitt County Memorial
SINGH, Nalini, MD, MPH
Professor of Pediatrics
Epidemiology and International Health
George Washington University
Children's National Medical Center
SOULE, Barbara M., RN, MPA, CIC
Practice Leader
Infection Prevention Services
Joint Commission Resources/Joint
Commission International
SCHECTER, William, P., MD
Department of Surgery, Ward 3A 17
San Francisco General Hospital
STEVENSON, Kurt Brown, MD, MPH
Division of Infectious Diseases
Department of Internal Medicine
The Ohio State University Medical Center



Ex-officio Members

Agency for Healthcare Research and Quality Ex-Officio
BAINE, William B., MD
Senior Medical Advisor
Center for Outcomes and Evidence
Agency for Healthcare Research and Quality
National Institute of Health
Ex-Officio
HENDERSON, David, MD
Deputy Director for Clinical Care
National Institute of Health
Health Resources and Services
Administration Ex-Officio
JAY, Lorine J., MPH, RN, CPHQ
Regional Coordinator
Food and Drug Administration
Ex-Officio
MURPHEY, Sheila A., MD Chief, Infection Control Devices Branch
Division of Anesthesiology, General Hospital Infection Control and Dental Devices
Center for Devices and Radiology Health
Food and Drug Administration
Center for Medicare & Medicaid Services (CMS) Ex-Officio
MILLER, Jeannie RN, MPH
Deputy Director, Office of Clinical Standards and Quality/ Clinical Standards Group
Department of Veterans Affairs (VA)
ROSELLE, Gary A., MD
National Program Director, Infectious Diseases
VA Central Office
Cincinnati VA Medical Center

Liaisons

Association of Professionals of Infection
Control and Epidemiology, Inc.
BJERKE, Nancy BSN, RN, MPH, CIC
KAINER, Marion MD, MPH Medical Epidemiologist/Infections
Diseases Physician Director, Hospital Infections and Antimicrobial Resistance
Program, Tennessee Department of Health
Infection Control Consultant
Infection Control Associates
American Health Care Association
FITZLER, Sandra L., RN
Senior Director of Clinical Services
American Health Care Association
American College of Occupational and Environmental Medicine
RUSSI, Mark, MD, MPH
American College of Occupational and Environmental Medicine
Advisory Council for the Elimination of
Tuberculosis STRICOF, Rachel L., MPH
New York State Department of Health
American Hospital Association
SCHULMAN, Roslyne, MHA, MBA
Senior Associate Director, Policy
Development
Association of periOperative Registered
Nurses
BLANCHARD, Joan C., RN, BSN,
MSS, CNOR, CIC
Association of periOperative Registered
Nurses
Society for Healthcare Epidemiology of America
MARAGAKIS, Lisa, MD Assistant Professor of Medicine Johns Hopkins Medical Institutions
Joint Commission on Accreditation of
Healthcare Organizations
WISE, Robert A., MD
Division of Standards & Survey
Methods
Joint Commission on Accreditation of
Healthcare Organizations
Consumers Union
Senior Policy Analyst on
MCGIFFERT, Lisa
Health Issues, Project Director
Stop Hospital Infections Organization



Acknowledgement

HICPAC thanks the following members who served on the HICPAC CAUTI Guideline subcommittee during the guideline development process: Russell N. Olmsted, MPH, Yvette S. McCarter, PhD, Barbara M. Soule, RN, MPA, CIC, and Nalini Singh, MD, MPH.
HICPAC thanks the following outside experts for reviewing a draft of this guideline: Edward S. Wong, MD, Lindsay E. Nicolle, MD, Anthony J. Schaeffer, MD, and Harriett M. Pitt, RN, MS, CIC. The opinions of the reviewers might not be reflected in all the recommendations contained in this document.
HICPAC would also like to thank the many individuals and organizations who provided valuable feedback on the guideline during the public comment period.

Disclosure of Financial Interests and Relationships

The authors C.V.G., C.A.U., R.K.A., and G.K. report no actual or potential conflicts of interest. D.A.P. is on the Speakers Bureau of Merck, Pfizer, Schering, and Cubist and is a consultant for Dow Pharmaceuticals, DaVita, and Vasonova. C.A.U. and R.K.A. received funding from the CDC to support the guideline development process.

No hay comentarios: